On the fly News and insights, exclusive to thefly.com

2021-08-04 10:16:12 HZNP Horizon Therapeutics $108.17 / +8.42 (+8.44%) 10:16 08/04/21 08/04 10:16 08/04/21 10:16	Horizon Therapeutics jumps on earnings beat, stronger guidance Shares of Horizon Therapeutics (HZNP) are on the rise on Wednesday after the company reported better-than-expected quarterly results and increased its full year revenue guidance. RESULTS: Horizon Therapeutics reported second quarter earnings per share of $1.62, which was better than the expected 88c. This compares to earnings of 40c per share a year ago. The company also reported revenue of $832.5M for the quarter, with consensus at $685.03M. This compares to year-ago revenues of $462.8M. Additionally, Horizon increased its full year 2021 net sales guidance to $3.025B-$3.125B, and its full year 2021 adjusted EBITDA guidance to $1.26B-$1.30B. PRICE ACTION: In Wednesday morning trading, shares of Horizon Therapeutics have gained almost 10% to $109.65.	04 Aug 07 Aug

2021-08-04 10:16:12

HZNP

Horizon Therapeutics

$108.17 / +8.42 (+8.44%)

10:16

08/04/21

08/04

10:16

08/04/21

10:16

Horizon Therapeutics jumps on earnings beat, stronger guidance

Shares of Horizon Therapeutics (HZNP) are on the rise on Wednesday after the company reported better-than-expected quarterly results and increased its full year revenue guidance. RESULTS: Horizon Therapeutics reported second quarter earnings per share of $1.62, which was better than the expected 88c. This compares to earnings of 40c per share a year ago. The company also reported revenue of $832.5M for the quarter, with consensus at $685.03M. This compares to year-ago revenues of $462.8M. Additionally, Horizon increased its full year 2021 net sales guidance to $3.025B-$3.125B, and its full year 2021 adjusted EBITDA guidance to $1.26B-$1.30B. PRICE ACTION: In Wednesday morning trading, shares of Horizon Therapeutics have gained almost 10% to $109.65.